US4783443A
(en)
|
1986-03-03 |
1988-11-08 |
The University Of Chicago |
Amino acyl cephalosporin derivatives
|
US5877016A
(en)
|
1994-03-18 |
1999-03-02 |
Genentech, Inc. |
Human trk receptors and neurotrophic factor inhibitors
|
US5844092A
(en)
|
1994-03-18 |
1998-12-01 |
Genentech, Inc. |
Human TRK receptors and neurotrophic factor inhibitors
|
US6677135B1
(en)
|
1996-05-08 |
2004-01-13 |
Biogen, Inc. |
Ret ligand (RetL) for stimulating neutral and renal growth
|
PT914339E
(pt)
|
1996-05-08 |
2006-12-29 |
Biogen Idec Inc |
Ligando ret (retl) para estimular o crescimento neural e renal
|
US6682921B1
(en)
|
1996-08-21 |
2004-01-27 |
New York University |
Crystals of the tyrosine kinase domain of non-insulin receptor tyrosine kinases
|
US6531152B1
(en)
|
1998-09-30 |
2003-03-11 |
Dexcel Pharma Technologies Ltd. |
Immediate release gastrointestinal drug delivery system
|
AU7103900A
(en)
|
1999-09-01 |
2001-03-26 |
Biogen, Inc. |
Ret ligand 5 (retl5) compositions and uses thereof
|
FI20000403A0
(fi)
|
2000-02-22 |
2000-02-22 |
Hannu Sariola |
GDNF perhesukuisten yhdisteiden käyttö kivessyövän hoitoon tarkoitettujen tuotteiden valmistamiseksi
|
BR0112272A
(pt)
|
2000-06-22 |
2003-05-06 |
Genentech Inc |
Anticorpo monoclonal anti-trkc agonista, cadeia pesada de anticorpo anti-trkc, cadeia leve de anticorpo anti-trkc, cadeia pesada de anticorpo anti-trkc murino, cadeia pesada de anticorpo anti-trkc humano, anticorpo agonista anti-trkc murino, anticorpo agonista anti-trkc humano, moléculas de ácido nucléico isolado, moléculas de ácido nucléico, vetor, linhagens de células hospedeiras, linhagens de células de hibridoma, célula hospedeira, polipeptìdeo, composição farmacêutica, método para o tratamento de neuropatia ou doença neurodegenerativa ou reparo de uma célula nervosa lesionada, método para aumentar a proliferação, manutenção ou regeneração de neurÈnios periféricos, método para o tratamento de doença ou condição que envolve a degeneração celular em um paciente mamìfero, método de indução de angiogênese, método de fabricação de um anticorpo anti-trkc, usos de um anticorpo
|
AU2002334355A1
(en)
|
2001-09-06 |
2003-03-18 |
Prochon Biotech Ltd. |
Protein tyrosine kinase inhibitors
|
US7466344B2
(en)
|
2002-06-07 |
2008-12-16 |
Scimeasure Analytical Systems, Inc. |
High-speed low noise CCD controller
|
ITMI20021620A1
(it)
|
2002-07-23 |
2004-01-23 |
Novuspharma Spa |
Composto ad ativita' antitumorale
|
EP1526854A1
(en)
|
2002-07-24 |
2005-05-04 |
University Of Cincinnati |
4-4(methylpiperazin-1-ylmethyl)-n- 4-methyl-3-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl -benzamide for treating mutated-ret kinase associated diseases
|
JP4634367B2
(ja)
|
2003-02-20 |
2011-02-16 |
スミスクライン ビーチャム コーポレーション |
ピリミジン化合物
|
US20090143399A1
(en)
|
2003-10-14 |
2009-06-04 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Protein Kinase Inhibitors
|
EP1682564A1
(en)
|
2003-10-27 |
2006-07-26 |
Genelabs Technologies, Inc. |
METHODS FOR PREPARING 7-(2 -SUBSTITUTED-s-D-RIBOFURANO SYL)-4-(NR2R3)-5-(SUBSTITUTED ETHYN-1-YL)-PYRROLO 2,3-D|PYRIMIDINE DERIVATIVES
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
ATE400573T1
(de)
|
2003-11-21 |
2008-07-15 |
Novartis Pharma Gmbh |
1h-imidazochinolinderivate als proteinkinaseinhibitoren
|
JP2007515400A
(ja)
|
2003-11-28 |
2007-06-14 |
ノバルティス アクチエンゲゼルシャフト |
タンパク質キナーゼ依存性疾患の処置におけるジアリール尿素誘導体
|
EP1696920B8
(en)
|
2003-12-19 |
2015-05-06 |
Plexxikon Inc. |
Compounds and methods for development of ret modulators
|
GB0330042D0
(en)
|
2003-12-24 |
2004-01-28 |
Pharmacia Italia Spa |
Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions them
|
GB0330043D0
(en)
|
2003-12-24 |
2004-01-28 |
Pharmacia Italia Spa |
Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them
|
WO2005068424A1
(en)
|
2004-01-20 |
2005-07-28 |
Cell Therapeutics Europe S.R.L. |
Indolinone derivatives as receptor tyrosine kinase ihibitors
|
PE20051089A1
(es)
|
2004-01-22 |
2006-01-25 |
Novartis Ag |
Derivados de pirazolo [1,5-a] pirimidin-7-il-amina como inhibidores de quinasa de proteina
|
US20050222171A1
(en)
|
2004-01-22 |
2005-10-06 |
Guido Bold |
Organic compounds
|
WO2005099363A2
(en)
|
2004-03-26 |
2005-10-27 |
Whitehead Institute For Biomedical Research |
Methods of diagnosing, preventing and treating cancer metastasis
|
GB0512324D0
(en)
|
2005-06-16 |
2005-07-27 |
Novartis Ag |
Organic compounds
|
CN101052629A
(zh)
*
|
2004-08-02 |
2007-10-10 |
Osi制药公司 |
芳基-氨基取代的吡咯并嘧啶多激酶抑制化合物
|
TW200615268A
(en)
|
2004-08-02 |
2006-05-16 |
Osi Pharm Inc |
Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds
|
PE20060664A1
(es)
|
2004-09-15 |
2006-08-04 |
Novartis Ag |
Amidas biciclicas como inhibidores de cinasa
|
WO2006050076A1
(en)
|
2004-10-29 |
2006-05-11 |
Janssen Pharmaceutica, N.V. |
Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
|
DE102005003687A1
(de)
|
2005-01-26 |
2006-07-27 |
Sphingo Tec Gmbh |
Immunoassay zur Bestimmung der Freisetzung von Neurotensin in die Zirkulation
|
GB0501999D0
(en)
|
2005-02-01 |
2005-03-09 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
CN101257948A
(zh)
|
2005-02-18 |
2008-09-03 |
阿特努奥恩公司 |
嘧啶并二氮䓬衍生物及吲哚并蝶啶化合物
|
GB0507575D0
(en)
|
2005-04-14 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
US7402579B2
(en)
|
2005-04-15 |
2008-07-22 |
Cylene Pharmaceuticals, Inc. |
Quinobenzoxazine analogs and compositions
|
BRPI0610184A2
(pt)
|
2005-05-16 |
2012-09-25 |
Astrazeneca Ab |
composto, sal farmaceuticamente aceitável de um composto, processo para preparar um composto ou um sal farmaceuticamente aceitável do mesmo, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, métodos para a inibição da atividade de trk, para o tratamento ou profilaxia de cáncer e para a produção de um efeito anti-proliferativo em um animal de sanque quente, e, composição farmacêutica
|
WO2006128042A2
(en)
|
2005-05-26 |
2006-11-30 |
The Johns Hopkins University |
Methods of identifying mutations in nucleic acid
|
WO2006130673A1
(en)
|
2005-05-31 |
2006-12-07 |
Janssen Pharmaceutica, N.V. |
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
|
CA2650999A1
(en)
|
2005-05-31 |
2006-12-07 |
The Pfahl Family Trust (Dated 9 July 1996) |
Substituted biarylheterocycle derivatives as protein kinase inhibitors for the treatment of cancer and other diseases
|
ITRM20050290A1
(it)
|
2005-06-07 |
2006-12-08 |
Lay Line Genomics Spa |
Uso di molecole in grado di inibire il legame tra ngf e il suo recettore trka come analgesici ad effetto prolungato.
|
TWI522337B
(zh)
|
2005-06-22 |
2016-02-21 |
普雷辛肯公司 |
用於激酶調節的化合物及方法及其適應症
|
GB0515026D0
(en)
|
2005-07-21 |
2005-08-31 |
Novartis Ag |
Organic compounds
|
JP5366548B2
(ja)
|
2005-08-25 |
2013-12-11 |
クレアビリス・セラピューティクス・エスピーエー |
K‐252aおよびその誘導体のポリマー結合体
|
WO2007053776A1
(en)
|
2005-11-03 |
2007-05-10 |
Sgx Pharmaceuticals, Inc. |
Pyrimidinyl-thiophene kinase modulators
|
EP1785420A1
(en)
|
2005-11-14 |
2007-05-16 |
4Sc Ag |
Thiazole analogues and uses thereof
|
US20070149523A1
(en)
|
2005-11-14 |
2007-06-28 |
Jan Ehlert |
Thiazole Analogues and Uses Thereof
|
WO2007057397A1
(en)
|
2005-11-15 |
2007-05-24 |
Boehringer Ingelheim International Gmbh |
Treatment of cancer
|
WO2007057399A2
(en)
|
2005-11-15 |
2007-05-24 |
Boehringer Ingelheim International Gmbh |
Treatment of cancer with indole derivatives
|
GB0524436D0
(en)
|
2005-11-30 |
2006-01-11 |
Novartis Ag |
Organic compounds
|
WO2007065664A2
(en)
|
2005-12-08 |
2007-06-14 |
Novartis Ag |
Pyrazolo[1,5-a]pyridine-3-carboxylic acids as ephb and vegfr2 kinase inhibitors
|
JP5474354B2
(ja)
|
2005-12-30 |
2014-04-16 |
アステックス、セラピューティックス、リミテッド |
医薬化合物
|
US20090227598A1
(en)
|
2006-01-24 |
2009-09-10 |
Buser-Doepner Carolyn A |
Ret Tyrosine Kinase Inhibition
|
US8012966B2
(en)
|
2006-01-27 |
2011-09-06 |
Shanghai Hengrui Pharmaceutical Co., Ltd. |
Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors
|
CN101563336A
(zh)
|
2006-03-16 |
2009-10-21 |
诺瓦提斯公司 |
用于治疗特别是黑素瘤的杂环有机化合物
|
ES2422890T3
(es)
|
2006-03-17 |
2013-09-16 |
Ambit Biosciences Corporation |
Compuestos de imidazolotiazol para el tratamiento de enfermedades proliferativas
|
EP2004623B1
(en)
|
2006-03-27 |
2013-10-09 |
Nerviano Medical Sciences S.r.l. |
Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
|
AU2007254491A1
(en)
|
2006-05-15 |
2007-11-29 |
Irm Llc |
Compositions and methods for FGF receptor kinases inhibitors
|
US20090209580A1
(en)
|
2006-05-18 |
2009-08-20 |
Eisai R & D Management Co., Ltd. |
Antitumor agent for thyroid cancer
|
US8063225B2
(en)
|
2006-08-14 |
2011-11-22 |
Chembridge Corporation |
Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
|
EP2067039A2
(en)
|
2006-09-12 |
2009-06-10 |
Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute for Biomedical Research |
Non-neuroendocrine cancer therapy
|
WO2008033562A2
(en)
|
2006-09-15 |
2008-03-20 |
Xcovery, Inc. |
Kinase inhibitor compounds
|
US20120225057A1
(en)
|
2006-10-11 |
2012-09-06 |
Deciphera Pharmaceuticals, Llc |
Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases
|
EP1918291A1
(en)
|
2006-10-30 |
2008-05-07 |
Novartis AG |
3-Aminocarbonyl-substituted fused pyrazolo-derivatives as protein kinase modulators
|
SI2848610T1
(en)
|
2006-11-15 |
2018-02-28 |
Ym Biosciences Australia Pty Ltd |
Inhibitors of kinase activity
|
CN101641351A
(zh)
|
2006-12-21 |
2010-02-03 |
普莱希科公司 |
用于激酶调节的化合物和方法及其适应症
|
PE20121126A1
(es)
|
2006-12-21 |
2012-08-24 |
Plexxikon Inc |
Compuestos pirrolo [2,3-b] piridinas como moduladores de quinasa
|
WO2008079909A1
(en)
|
2006-12-21 |
2008-07-03 |
Plexxikon, Inc. |
Pyrrolo [2,3-b] pyridines as kinase modulators
|
US20080199426A1
(en)
|
2007-01-11 |
2008-08-21 |
Sukhatme Vikas P |
Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders
|
WO2008089388A2
(en)
|
2007-01-19 |
2008-07-24 |
Bayer Healthcare Llc |
Treatment of cancers having resistance to chemotherapeutic agents
|
US20080234267A1
(en)
|
2007-03-20 |
2008-09-25 |
Karen Elizabeth Lackey |
Compounds and Methods of Treatment
|
US20110189167A1
(en)
|
2007-04-20 |
2011-08-04 |
Flynn Daniel L |
Methods and Compositions for the Treatment of Myeloproliferative Diseases and other Proliferative Diseases
|
EP2152688A1
(en)
|
2007-05-04 |
2010-02-17 |
Irm Llc |
Compounds and compositions as c-kit and pdgfr kinase inhibitors
|
WO2008138184A1
(fr)
|
2007-05-14 |
2008-11-20 |
Shanghai Hengrui Pharmaceutical Co.Ltd. |
Dérivés de pyrrolo-azacycles, leur procédé de fabrication et leur utilisation en tant qu'inhibiteurs de protéine kinases
|
US20090012045A1
(en)
|
2007-06-26 |
2009-01-08 |
Rigel Pharmaceuticals, Inc. |
Methods of Treating Cell Proliferative Disorders
|
CA2692945A1
(en)
|
2007-07-09 |
2009-01-15 |
Astrazeneca Ab |
Compounds - 945
|
US20100209488A1
(en)
|
2007-07-16 |
2010-08-19 |
The Regents Of The University Of California |
Protein kinase modulating compounds and methods for making and using them
|
SG183036A1
(en)
|
2007-07-17 |
2012-08-30 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
US8293747B2
(en)
|
2007-07-19 |
2012-10-23 |
Merck Sharp & Dohme Corp. |
Heterocyclic amide compounds as protein kinase inhibitors
|
NZ583450A
(en)
|
2007-07-20 |
2012-05-25 |
Nerviano Medical Sciences Srl |
Substituted indazole derivatives active as kinase inhibitors
|
WO2009017838A2
(en)
|
2007-08-01 |
2009-02-05 |
Exelixis, Inc. |
Combinations of jak-2 inhibitors and other agents
|
JP5703466B2
(ja)
|
2007-08-07 |
2015-04-22 |
パーデュー・リサーチ・ファウンデーションPurdue Research Foundation |
キナーゼ阻害薬およびその使用
|
EP2025678A1
(en)
|
2007-08-17 |
2009-02-18 |
Oncalis AG |
Pyrazolo[3,4-d]pyrimidine compounds and their use as modulators of protein kinase
|
WO2009042646A1
(en)
|
2007-09-24 |
2009-04-02 |
Curis, Inc. |
Anti-proliferative agents
|
EA201000603A1
(ru)
|
2007-10-23 |
2010-12-30 |
Новартис Аг |
ПРИМЕНЕНИЕ АНТИТЕЛ К TrkB ДЛЯ ЛЕЧЕНИЯ РЕСПИРАТОРНЫХ НАРУШЕНИЙ
|
JP5400791B2
(ja)
|
2007-12-04 |
2014-01-29 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
置換ジヒドロプテリジン−6−オン誘導体、その製造方法及びキナーゼ阻害剤としてのその使用
|
CN101459004B
(zh)
|
2007-12-14 |
2011-02-09 |
深圳富泰宏精密工业有限公司 |
电子装置的按键面板结构及制造该按键面板结构的方法
|
JP5420568B2
(ja)
|
2008-01-17 |
2014-02-19 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
改良された抗TrkB抗体
|
JP2009203226A
(ja)
|
2008-01-31 |
2009-09-10 |
Eisai R & D Management Co Ltd |
ピリジン誘導体およびピリミジン誘導体を含有するレセプターチロシンキナーゼ阻害剤
|
TW200942537A
(en)
|
2008-02-01 |
2009-10-16 |
Irm Llc |
Compounds and compositions as kinase inhibitors
|
US20090209496A1
(en)
|
2008-02-15 |
2009-08-20 |
David Chaplin |
Methods and compositions for enhancing the efficacy of rtk inhibitors
|
PT2268623E
(pt)
*
|
2008-03-17 |
2015-09-17 |
Ambit Biosciences Corp |
Derivados de quinazolina como moduladores de cinase raf e métodos para utilização dos mesmos
|
DK2262807T3
(en)
|
2008-03-19 |
2015-11-30 |
Chembridge Corp |
NOVEL tyrosine kinase inhibitors
|
US8207165B2
(en)
|
2008-03-28 |
2012-06-26 |
Nerviano Medical Sciences S.R.L. |
3,4-dihydro-2H-pyrazino[1,2-A]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
WO2009143018A2
(en)
|
2008-05-19 |
2009-11-26 |
Plexxikon, Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
PE20091846A1
(es)
|
2008-05-19 |
2009-12-16 |
Plexxikon Inc |
DERIVADOS DE PIRROLO[2,3-d]-PIRIMIDINA COMO MODULADORES DE CINASAS
|
EA021421B1
(ru)
|
2008-05-23 |
2015-06-30 |
Новартис Аг |
Производные хинолинов и хиноксалинов в качестве ингибиторов протеинтирозинкиназы, способ их получения, содержащая их фармацевтическая композиция и способ лечения заболеваний с применением таких соединений
|
WO2009152083A1
(en)
|
2008-06-10 |
2009-12-17 |
Plexxikon, Inc. |
5h-pyrr0l0 [2,3-b] pyrazine derivatives for kinase modulation, and indications therefor
|
US20110212053A1
(en)
|
2008-06-19 |
2011-09-01 |
Dapeng Qian |
Phosphatidylinositol 3 kinase inhibitors
|
WO2010006432A1
(en)
|
2008-07-14 |
2010-01-21 |
Queen's University At Kingston |
Pharmaceutical compositions comprising ret inhibitors and methods for the treatment of cancer
|
WO2010012733A1
(en)
|
2008-07-29 |
2010-02-04 |
Nerviano Medical Sciences S.R.L. |
Use of a cdk inhibitor for the treatment of glioma
|
EP2352361B1
(en)
|
2008-09-01 |
2014-09-24 |
Sharp Kabushiki Kaisha |
Organic electroluminescence panel, organic electroluminescence display, organic electroluminescence illumination and method for manufacturing such panel, display and illumination
|
WO2010028254A2
(en)
|
2008-09-05 |
2010-03-11 |
Auspek Pharmaceuticals, Inc. |
Substituted quinazoline inhibitors of growth factor receptor tyrosine kinases
|
EP2161271A1
(en)
|
2008-09-08 |
2010-03-10 |
Università Degli Studi Di Milano - Bicocca |
Alpha-carboline inhibitors of NMP-ALK, RET, and Bcr-Abl
|
JP5746032B2
(ja)
|
2008-09-19 |
2015-07-08 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
3,4−ジヒドロ−2H−ピロロ[1,2−a]ピラジン−1−オン誘導体
|
RS53350B
(en)
|
2008-09-22 |
2014-10-31 |
Array Biopharma, Inc. |
SUBSTITUTED COMPOUNDS OF IMIDASO [1,2-B] PYRIDASINE AS INK KINASE INHIBITORS
|
US9006252B2
(en)
|
2008-09-26 |
2015-04-14 |
National Health Research Institutes |
Fused multicyclic compounds as protein kinase inhibitors
|
EP3372605B1
(en)
|
2008-10-22 |
2021-11-03 |
Array Biopharma, Inc. |
Substituted pyrazolo[1,5-a]pyrimidine compounds as trk kinase inhibitors
|
JP5686736B2
(ja)
|
2008-11-06 |
2015-03-18 |
アムビト ビオスシエンセス コルポラチオン |
プロテインキナーゼモジュレーターとしてのイミダゾロチアゾール化合物
|
WO2010058006A1
(en)
|
2008-11-24 |
2010-05-27 |
Nerviano Medical Sciences S.R.L. |
Cdk inhibitor for the treatment of mesothelioma
|
KR101061599B1
(ko)
|
2008-12-05 |
2011-09-02 |
한국과학기술연구원 |
비정상 세포 성장 질환의 치료를 위한 단백질 키나아제 저해제인 신규 인다졸 유도체, 이의 약학적으로 허용가능한염 및 이를 유효성분으로 함유하는 약학적 조성물
|
JO3265B1
(ar)
|
2008-12-09 |
2018-09-16 |
Novartis Ag |
مثبطات بيريديلوكسى اندولات vegf-r2 واستخدامها لعلاج المرض
|
WO2010111527A1
(en)
|
2009-03-26 |
2010-09-30 |
Plexxikon, Inc. |
Pyrazolo [ 3, 4 -b] pyridines as kinase inhibitors and their medical use
|
TWI410418B
(zh)
|
2009-04-29 |
2013-10-01 |
Ind Tech Res Inst |
氮雜薁化合物、藥學組合物與抑制一細胞中蛋白質激酶之活性的方法
|
PL2428508T3
(pl)
|
2009-05-08 |
2016-05-31 |
Astellas Pharma Inc |
Diaminoheterocykliczny związek karboksyamidowy
|
US8765747B2
(en)
|
2009-06-12 |
2014-07-01 |
Dana-Farber Cancer Institute, Inc. |
Fused 2-aminothiazole compounds
|
JP5789602B2
(ja)
|
2009-06-15 |
2015-10-07 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
置換ピリミジニルピロロピリジノン誘導体、これらの製造のための方法およびキナーゼ阻害剤としてのこれらの使用
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
WO2011022439A1
(en)
*
|
2009-08-17 |
2011-02-24 |
Intellikine, Inc. |
Heterocyclic compounds and uses thereof
|
KR101256018B1
(ko)
|
2009-08-20 |
2013-04-18 |
한국과학기술연구원 |
단백질 키나아제 저해활성을 갖는 1,3,6-치환된 인돌 화합물
|
CN102482283A
(zh)
*
|
2009-08-28 |
2012-05-30 |
阵列生物制药公司 |
Raf抑制剂化合物及其使用方法
|
US20120157452A1
(en)
*
|
2009-08-28 |
2012-06-21 |
Genentech, Inc. |
1h-pyrazolo[3,4-b] pyridine compounds for inhibiting raf kinase
|
FR2951172B1
(fr)
|
2009-10-13 |
2014-09-26 |
Pf Medicament |
Derives pyrazolopyridines en tant qu'agent anticancereux
|
KR101147550B1
(ko)
|
2009-10-22 |
2012-05-17 |
한국과학기술연구원 |
단백질 키나아제 저해활성을 가지는 2,7-치환된 티에노[3,2-d]피리미딘 화합물
|
KR101116756B1
(ko)
|
2009-10-27 |
2012-03-13 |
한국과학기술연구원 |
단백질 키나아제 저해활성을 갖는 신규의 1,6-치환된 인돌 화합물
|
KR101690358B1
(ko)
|
2009-10-29 |
2017-01-09 |
제노스코 |
키나아제 억제제
|
BR112012011287B1
(pt)
|
2009-11-13 |
2022-02-08 |
Genosco |
Compostos inibidores de cinase derivados de pirolopirimidina, sua formulação farmacêutica e seus usos
|
KR101094446B1
(ko)
|
2009-11-19 |
2011-12-15 |
한국과학기술연구원 |
단백질 키나아제 저해활성을 가지는 2,4,7-치환된 티에노[3,2-d]피리미딘 화합물
|
EP2519517B1
(en)
|
2009-12-29 |
2015-03-25 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
CA2786438C
(en)
|
2010-01-29 |
2015-10-13 |
Hanmi Science Co., Ltd. |
Thieno[3,2-d]pyrimidine derivatives having inhibitory activity on protein kinases
|
WO2011092120A1
(en)
|
2010-01-29 |
2011-08-04 |
Nerviano Medical Sciences S.R.L. |
6,7- dihydroimidazo [1,5-a] pyrazin-8 (5h) - one derivatives as protein kinase modulators
|
KR101483215B1
(ko)
|
2010-01-29 |
2015-01-16 |
한미약품 주식회사 |
단백질 키나아제 저해활성을 갖는 비시클릭 헤테로아릴 유도체
|
JP2013519706A
(ja)
|
2010-02-18 |
2013-05-30 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
癌転移を予防するための方法
|
TWI619713B
(zh)
|
2010-04-21 |
2018-04-01 |
普雷辛肯公司 |
用於激酶調節的化合物和方法及其適應症
|
ES2481873T3
(es)
*
|
2010-05-12 |
2014-07-31 |
Abbvie Inc. |
Pirrolopiridina y pirrolopirimidina inhibidores de quinasas
|
PL3205654T3
(pl)
|
2010-05-20 |
2019-08-30 |
Array Biopharma, Inc. |
Związki makrocykliczne jako inhibitory kinazy TRK
|
WO2012034095A1
(en)
|
2010-09-09 |
2012-03-15 |
Irm Llc |
Compounds and compositions as trk inhibitors
|
US8637516B2
(en)
|
2010-09-09 |
2014-01-28 |
Irm Llc |
Compounds and compositions as TRK inhibitors
|
WO2012037155A2
(en)
|
2010-09-13 |
2012-03-22 |
Gtx, Inc. |
Tyrosine kinase inhibitors
|
WO2012047017A2
(ko)
|
2010-10-05 |
2012-04-12 |
크리스탈지노믹스(주) |
2,3-디히드로-이소인돌-1-온 유도체 및 이를 포함하는 조성물
|
JP2014005206A
(ja)
|
2010-10-22 |
2014-01-16 |
Astellas Pharma Inc |
アリールアミノヘテロ環カルボキサミド化合物
|
EP2668190B1
(en)
|
2011-01-26 |
2016-08-17 |
Nerviano Medical Sciences S.r.l. |
Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
|
WO2012101029A1
(en)
|
2011-01-26 |
2012-08-02 |
Nerviano Medical Sciences S.R.L. |
Tricyclic derivatives, process for their preparation and their use as kinase inhibitors
|
CN102093421B
(zh)
|
2011-01-28 |
2014-07-02 |
北京康辰药业有限公司 |
一种含磷取代基的喹啉类化合物及其制备方法、以及含有该化合物的药物组合物及其应用
|
MY162950A
(en)
|
2011-02-07 |
2017-07-31 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
RU2606497C2
(ru)
|
2011-02-24 |
2017-01-10 |
НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. |
Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ
|
AP2013007103A0
(en)
|
2011-02-25 |
2013-09-30 |
Irm Llc |
Compounds and compositions as TRK inhibitors
|
WO2012135631A1
(en)
|
2011-03-30 |
2012-10-04 |
Arrien Pharmaeuticals Llc |
Substituted 5-(pyrazin-2-yl)-1h-pyrazolo [3, 4-b] pyridine and pyrazolo [3, 4-b] pyridine derivatives as protein kinase inhibitors
|
BR112013025387B1
(pt)
|
2011-04-01 |
2021-07-27 |
University Of Utah Research Foundation |
Compostos análogos substituídos da n-fenilpirimidin-2-amina como inibidores da quinase axl, uso dos ditos compostos para o tratamento de um distúrbio de proliferação celular descontrolada, bem como kit compreendendo ditos compostos
|
EP2702055A1
(en)
|
2011-04-11 |
2014-03-05 |
Nerviano Medical Sciences S.r.l. |
Pyrazolyl-pyrimidine derivatives as kinase inhibitors
|
JP5970537B2
(ja)
|
2011-04-19 |
2016-08-17 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
キナーゼ阻害薬として活性な置換ピリミジニル−ピロール
|
AR086042A1
(es)
*
|
2011-04-28 |
2013-11-13 |
Galapagos Nv |
Compuesto util para el tratamiento de enfermedades degenerativas e inflamatorias y composicion farmaceutica
|
ES2611779T3
(es)
|
2011-05-12 |
2017-05-10 |
Nerviano Medical Sciences S.R.L. |
Derivados de indazol sustituidos activos como inhibidores de quinasas
|
NZ618795A
(en)
|
2011-05-13 |
2015-07-31 |
Array Biopharma Inc |
Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors
|
RU2477723C2
(ru)
|
2011-06-16 |
2013-03-20 |
Общество С Ограниченной Ответственностью "Фьюжн Фарма" |
Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
|
CN102827073A
(zh)
*
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
WO2013016720A2
(en)
|
2011-07-28 |
2013-01-31 |
Gerinda Therapeutics, Inc. |
Novel substituted biarylheterocycle derivatives as protein kinase inhibitors for the treatment of cancer and other diseases
|
JP6016915B2
(ja)
|
2011-07-28 |
2016-10-26 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
キナーゼ阻害剤として活性なアルキニル置換ピリミジニルピロール
|
EP2740742B1
(en)
|
2011-08-04 |
2018-03-14 |
National Cancer Center |
Fusion gene of kif5b gene and ret gene, and method for determining effectiveness of cancer treatment targeting fusion gene
|
BR112014004213A2
(pt)
|
2011-08-23 |
2017-06-20 |
Found Medicine Inc |
novas moléculas de fusão kif5b-ret e usos das mesmas
|
CA2846496C
(en)
|
2011-09-02 |
2020-07-14 |
The Regents Of The University Of California |
Substituted pyrazolo[3,4-d]pyrimidines and uses thereof
|
WO2013036232A2
(en)
|
2011-09-08 |
2013-03-14 |
Deciphera Pharmaceuticals, Llc |
Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases
|
WO2013042137A1
(en)
|
2011-09-19 |
2013-03-28 |
Aurigene Discovery Technologies Limited |
Bicyclic heterocycles as irak4 inhibitors
|
CN102408411B
(zh)
|
2011-09-19 |
2014-10-22 |
北京康辰药业股份有限公司 |
一种含喹啉基的羟肟酸类化合物及其制备方法、以及含有该化合物的药物组合物及其应用
|
WO2013050446A1
(en)
|
2011-10-07 |
2013-04-11 |
Nerviano Medical Sciences S.R.L. |
SUBSTITUTED 3,4-DIHYDROPYRROLO[1,2-a]PYRAZIN-1(2H)-ONE DERIVATIVES AS KINASES INHIBITORS
|
US9181258B2
(en)
|
2011-10-07 |
2015-11-10 |
Nerviano Medical Sciences S.R.L. |
Substituted 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-ones as protein kinase inhibitors
|
CN104202982A
(zh)
|
2011-11-14 |
2014-12-10 |
泰萨罗公司 |
调节某些酪氨酸激酶
|
WO2013081188A1
(ja)
|
2011-11-30 |
2013-06-06 |
独立行政法人国立がん研究センター |
誘導悪性幹細胞
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
SG11201402765TA
(en)
|
2011-12-30 |
2014-06-27 |
Hanmi Pharm Ind Co Ltd |
THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES
|
JP2015109806A
(ja)
|
2012-03-22 |
2015-06-18 |
アステラス製薬株式会社 |
新規ret融合体の検出法
|
ES2605388T3
(es)
|
2012-04-26 |
2017-03-14 |
Ono Pharmaceutical Co., Ltd. |
Compuesto inhibidor de Trk
|
CA2871540A1
(en)
|
2012-05-10 |
2013-11-14 |
Synta Pharmaceuticals Corp. |
Treating cancer with hsp90 inhibitory compounds
|
KR102151963B1
(ko)
|
2012-05-23 |
2020-09-07 |
네르비아노 메디칼 사이언시스 에스.알.엘. |
N-[5-(3,5-디플루오로-벤질)-1h-인다졸-3-일]-4-(4-메틸-피페라진-1-일)-2-(테트라하이드로-피란-4-일아미노)-벤즈아미드의 제조 방법
|
TWI585088B
(zh)
|
2012-06-04 |
2017-06-01 |
第一三共股份有限公司 |
作爲激酶抑制劑之咪唑并[1,2-b]嗒衍生物
|
RS62233B1
(sr)
|
2012-07-11 |
2021-09-30 |
Blueprint Medicines Corp |
Inhibitori receptora fibroblast faktora rasta
|
WO2014017491A1
(ja)
|
2012-07-26 |
2014-01-30 |
独立行政法人国立がん研究センター |
Cep55遺伝子とret遺伝子との融合遺伝子
|
RU2666538C2
(ru)
|
2012-08-02 |
2018-09-11 |
НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. |
Замещенные пирролы, активные в качестве ингибиторов киназ
|
ES2726605T3
(es)
|
2012-09-07 |
2019-10-08 |
Exelixis Inc |
Inhibidores de MET, VEGFR y RET para usar en el tratamiento del adenocarcinoma de pulmón
|
US10668075B2
(en)
|
2012-09-25 |
2020-06-02 |
Chugai Seiyaku Kabushiki Kaisha |
RET inhibitor
|
WO2014072220A1
(en)
|
2012-11-07 |
2014-05-15 |
Nerviano Medical Sciences S.R.L. |
Substituted pyrimidinyl and pyridinyl-pyrrolopyridinones, process for their preparation and their use as kinase inhibitors
|
BR112015010501A2
(pt)
|
2012-11-12 |
2017-07-11 |
Ignyta Inc |
composto, composição farmacêutica, nanopartículas, método para tratar câncer em um paciente e composição liofilizada
|
US9790210B2
(en)
|
2012-11-13 |
2017-10-17 |
Array Biopharma Inc. |
N-(monocyclic aryl),N'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
WO2014078417A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
US9981959B2
(en)
|
2012-11-13 |
2018-05-29 |
Array Biopharma Inc. |
Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
US9969694B2
(en)
|
2012-11-13 |
2018-05-15 |
Array Biopharma Inc. |
N-(arylalkyl)-N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
WO2014078328A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-bicyclic aryl,n'-pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
US9822118B2
(en)
|
2012-11-13 |
2017-11-21 |
Array Biopharma Inc. |
Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
US9828360B2
(en)
|
2012-11-13 |
2017-11-28 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
ME02879B
(me)
|
2012-11-13 |
2018-04-20 |
Array Biopharma Inc |
Jedinjenja biciklične uree, tiouree, guanidina i cijanoguanidina korisna za lečenje bola
|
US9790178B2
(en)
|
2012-11-13 |
2017-10-17 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
WO2014078323A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-pyrrolidinyl, n'-pyrazolyl- urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
WO2014083567A2
(en)
|
2012-11-29 |
2014-06-05 |
Yeda Research And Development Co. Ltd. |
Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors
|
WO2014086284A1
(zh)
|
2012-12-04 |
2014-06-12 |
上海医药集团股份有限公司 |
一类氘代3-氰基喹啉类化合物、其药用组合物、制备方法及其用途
|
US9758508B2
(en)
|
2012-12-28 |
2017-09-12 |
Crystalgenomics, Inc. |
2,3-dihydro-isoindole-1-on derivative as BTK kinase suppressant, and pharmaceutical composition including same
|
FR3000493A1
(fr)
|
2012-12-28 |
2014-07-04 |
Oribase Pharma |
Nouveaux inhibiteurs de proteines kinases
|
FR3000492B1
(fr)
|
2012-12-28 |
2015-09-11 |
Oribase Pharma |
Nouveaux derives azaindole en tant qu'inhibiteurs multikinases
|
FR3000494B1
(fr)
|
2012-12-28 |
2015-08-21 |
Oribase Pharma |
Nouveaux derives d'azaindoles en tant qu'inhibiteurs de proteines kinases
|
CN106928197A
(zh)
|
2013-02-19 |
2017-07-07 |
小野药品工业株式会社 |
Trk抑制化合物
|
WO2014160524A1
(en)
|
2013-03-14 |
2014-10-02 |
The Trustees Of The University Of Pennsylvania |
Cardio- metabolic and cascular effects of glp-1 metabolites
|
AR095308A1
(es)
|
2013-03-15 |
2015-10-07 |
Glaxosmithkline Ip Dev Ltd |
Compuesto de 2-piridona, composición farmacéutica que lo comprende y su uso para preparar un medicamento
|
WO2014160521A1
(en)
|
2013-03-15 |
2014-10-02 |
Blueprint Medicines Corporation |
Piperazine derivatives and their use as kit modulators
|
ME02664B
(me)
|
2013-03-15 |
2017-06-20 |
Glaxosmithkline Ip Dev Ltd |
Derivati premeštanja piridina u toku transfekcije inhibitora (ret) kinaze
|
JP6397897B2
(ja)
|
2013-05-14 |
2018-09-26 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
ピロロ[2,3−d]ピリミジン誘導体、その製造方法及びキナーゼ阻害剤としてのその使用
|
KR20160013028A
(ko)
|
2013-05-30 |
2016-02-03 |
플렉시콘, 인코퍼레이티드 |
키나제 조정을 위한 화합물 및 그에 대한 적응증
|
EP3027654B1
(en)
|
2013-07-30 |
2019-09-25 |
Blueprint Medicines Corporation |
Pik3c2g fusions
|
WO2015017533A1
(en)
|
2013-07-30 |
2015-02-05 |
Blueprint Medicines Corporation |
Ntrk2 fusions
|
JP6493681B2
(ja)
|
2013-08-20 |
2019-04-03 |
学校法人関西医科大学 |
肺がんで見出された新規融合遺伝子
|
WO2015031613A1
(en)
|
2013-08-30 |
2015-03-05 |
Ambit Biosciences Corporation |
Biaryl acetamide compounds and methods of use thereof
|
PT3057969T
(pt)
|
2013-10-17 |
2018-07-11 |
Blueprint Medicines Corp |
Composições úteis para tratar distúrbios relacionados com kit
|
WO2015058129A1
(en)
|
2013-10-17 |
2015-04-23 |
Blueprint Medicines Corporation |
Compositions useful for treating disorders related to kit
|
ES2924111T3
(es)
|
2013-10-25 |
2022-10-04 |
Blueprint Medicines Corp |
Inhibidores del receptor del factor de crecimiento de fibroblastos
|
GB201321146D0
(en)
|
2013-11-29 |
2014-01-15 |
Cancer Rec Tech Ltd |
Quinazoline compounds
|
WO2015082887A2
(en)
|
2013-12-02 |
2015-06-11 |
Bergenbio As |
Use of kinase inhibitors
|
WO2015100117A1
(en)
*
|
2013-12-26 |
2015-07-02 |
Cephalon, Inc. |
Pyrazolo[1,5-a]pyridine derivatives and methods of their use
|
US9695165B2
(en)
|
2014-01-15 |
2017-07-04 |
Blueprint Medicines Corporation |
Inhibitors of the fibroblast growth factor receptor
|
EA201892241A1
(ru)
|
2014-01-24 |
2019-02-28 |
ТиПи ТЕРАПЬЮТИКС, ИНК. |
Диарильные макроциклы в качестве модуляторов протеинкиназ
|
EP3738952A1
(en)
|
2014-02-14 |
2020-11-18 |
Exelixis, Inc. |
Crystalline solid forms of n-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
|
TWI672141B
(zh)
|
2014-02-20 |
2019-09-21 |
美商醫科泰生技 |
投予ros1突變癌細胞之分子
|
WO2015161277A1
(en)
|
2014-04-18 |
2015-10-22 |
Blueprint Medicines Corporation |
Met fusions
|
EP3132056B1
(en)
|
2014-04-18 |
2021-11-24 |
Blueprint Medicines Corporation |
Pik3ca fusions
|
MX2016014945A
(es)
|
2014-05-15 |
2017-03-27 |
Array Biopharma Inc |
1- ((3s,4r) -4- (3-fluorofenil) -1- (2-metoxietil) pirrolidin-3-il) -3- (4-metil-3- (2-metilpirimidin-5-il) -1-fenil-1h-pirazol-5-il) urea como inhibidor de trka cinasa.
|
WO2015191666A2
(en)
|
2014-06-10 |
2015-12-17 |
Blueprint Medicines Corporation |
Raf1 fusions
|
US10246750B2
(en)
|
2014-06-10 |
2019-04-02 |
Blueprint Medicines Corporation |
Method for detection of a TECR:PKN1 or an ANXA4:PKN1 gene fusion
|
US10370725B2
(en)
|
2014-07-17 |
2019-08-06 |
Blueprint Medicines Corporation |
FGR fusions
|
WO2016011147A1
(en)
|
2014-07-17 |
2016-01-21 |
Blueprint Medicines Corporation |
Prkc fusions
|
AU2015291522B2
(en)
|
2014-07-17 |
2018-12-06 |
Sunshine Lake Pharma Co., Ltd. |
Substituted urea derivatives and pharmaceutical uses thereof
|
WO2016011144A1
(en)
|
2014-07-17 |
2016-01-21 |
Blueprint Medicines Corporation |
Tert fusions
|
WO2016022569A1
(en)
|
2014-08-04 |
2016-02-11 |
Blueprint Medicines Corporation |
Compositions useful for treating disorders related to kit
|
KR20170042591A
(ko)
|
2014-08-18 |
2017-04-19 |
오노 야꾸힝 고교 가부시키가이샤 |
Trk 저해 화합물의 산부가염
|
WO2016038519A1
(en)
|
2014-09-08 |
2016-03-17 |
Glaxosmithkline Intellectual Property Development Limited |
Crystalline forms of 2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin-3-yl)-2-fluorophenyl)-n-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide
|
PE20170677A1
(es)
|
2014-09-10 |
2017-05-13 |
Glaxosmithkline Ip Dev Ltd |
Nuevos compuestos como inhibidores de reorganizado durante la transfeccion (ret)
|
DK3191450T3
(da)
|
2014-09-10 |
2019-05-20 |
Glaxosmithkline Ip Dev Ltd |
Pyridonderivater som kinasehæmmere omarrangeret under transfektion (ret)
|
TWI538914B
(zh)
|
2014-10-03 |
2016-06-21 |
國立交通大學 |
蛋白質激酶之選擇性抑制劑、其醫藥組成物及其用途
|
PL3218378T3
(pl)
|
2014-11-14 |
2020-10-19 |
Nerviano Medical Sciences S.R.L. |
Pochodne 6-amino-7-bicyklo-7-deazapuryny jako inhibitory kinaz białkowych
|
UA123044C2
(uk)
|
2014-11-16 |
2021-02-10 |
Ерей Біофарма Інк. |
КРИСТАЛІЧНА ФОРМА (S)-N-(5-((R)-2-(2,5-ДИФТОРФЕНІЛ)-ПІРОЛІДИН-1-ІЛ)-ПІРАЗОЛО[1,5-a]ПІРИМІДИН-3-ІЛ)-3-ГІДРОКСИПІРОЛІДИН-1-КАРБОКСАМІД ГІДРОСУЛЬФАТУ
|
US20170356052A1
(en)
|
2014-11-18 |
2017-12-14 |
Blueprint Medicines Corporation |
Prkacb fusions
|
EP3233840B1
(en)
|
2014-12-16 |
2018-11-21 |
Eudendron S.r.l. |
Heterocyclic derivatives modulating activity of certain protein kinases
|
US10202365B2
(en)
|
2015-02-06 |
2019-02-12 |
Blueprint Medicines Corporation |
2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
|
KR101675984B1
(ko)
|
2015-02-23 |
2016-11-14 |
한양대학교 에리카산학협력단 |
티에노디아제핀 유도체 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 포함하는 약학적 조성물
|
WO2016141169A1
(en)
|
2015-03-03 |
2016-09-09 |
Caris Mpi, Inc. |
Molecular profiling for cancer
|
CN108137593B
(zh)
|
2015-04-21 |
2021-01-05 |
上海交通大学医学院附属瑞金医院 |
蛋白激酶抑制剂的制备和用途
|
GB201512365D0
(en)
|
2015-07-15 |
2015-08-19 |
King S College London |
Novel therapy
|
KR20180041135A
(ko)
|
2015-07-16 |
2018-04-23 |
어레이 바이오파마 인크. |
Ret 키나아제 억제제로서 치환된 피라졸로[1,5-a]피리딘 화합물
|
EP3120851A1
(en)
|
2015-07-21 |
2017-01-25 |
Pangaea Biotech S.L. |
4-amino-6-(2,6-dichlorophenyl)-8-methyl-2-(phenylamino)-pyrido[2,3-d]pyrimidin-7(8h)-one for treatment of solid cancers
|
KR101766194B1
(ko)
|
2015-08-07 |
2017-08-10 |
한국과학기술연구원 |
RET 키나아제 저해제인 신규 3-(이속사졸-3-일)-피라졸로[3,4-d]피리미딘-4-아민 화합물
|
WO2017027883A1
(en)
|
2015-08-13 |
2017-02-16 |
San Diego State University Research Foundation |
Atropisomerism for increased kinase inhibitor selectivity
|
MA41559A
(fr)
|
2015-09-08 |
2017-12-26 |
Taiho Pharmaceutical Co Ltd |
Composé de pyrimidine condensé ou un sel de celui-ci
|
WO2017049462A1
(zh)
|
2015-09-22 |
2017-03-30 |
合肥中科普瑞昇生物医药科技有限公司 |
一类新型的flt3激酶抑制剂及其用途
|
CN105255927B
(zh)
|
2015-09-30 |
2018-07-27 |
温州医科大学附属第一医院 |
一种kiaa1217-ret融合基因
|
SG11201803653QA
(en)
|
2015-11-02 |
2018-05-30 |
Blueprint Medicines Corp |
Inhibitors of ret
|
JP2018537980A
(ja)
|
2015-12-08 |
2018-12-27 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
癌治療のための非小細胞肺癌(nsclc)および甲状腺癌患者を選択するためのバイオマーカーとしてret融合遺伝子を使用する方法
|
WO2017122815A1
(ja)
|
2016-01-15 |
2017-07-20 |
公益財団法人がん研究会 |
新規融合体及びその検出法
|
TWI620748B
(zh)
|
2016-02-05 |
2018-04-11 |
National Health Research Institutes |
氨基噻唑化合物及其用途
|
WO2017145050A1
(en)
|
2016-02-23 |
2017-08-31 |
Glaxosmithkline Intellectual Property Development Limited |
Pyridylpyridone derivative useful as a ret kinase inhibitor in the treatment of ibs and cancer
|
WO2017146116A1
(ja)
|
2016-02-23 |
2017-08-31 |
大鵬薬品工業株式会社 |
新規縮合ピリミジン化合物又はその塩
|
UY37155A
(es)
|
2016-03-17 |
2017-10-31 |
Blueprint Medicines Corp |
Inhibidores de ret
|
US10045991B2
(en)
|
2016-04-04 |
2018-08-14 |
Loxo Oncology, Inc. |
Methods of treating pediatric cancers
|
ES2925698T3
(es)
|
2016-04-15 |
2022-10-19 |
Cancer Research Tech Ltd |
Compuestos heterocíclicos como inhibidores de la quinasa RET
|
US10954241B2
(en)
|
2016-04-15 |
2021-03-23 |
Cancer Research Technology Limited |
Heterocyclic compounds as ret kinase inhibitors
|
TWI704148B
(zh)
|
2016-10-10 |
2020-09-11 |
美商亞雷生物製藥股份有限公司 |
作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
|
JOP20190077A1
(ar)
|
2016-10-10 |
2019-04-09 |
Array Biopharma Inc |
مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret
|